Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RLAY compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
RLAY
Relay Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RLAY
Relay Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
RLAY
Relay Therapeutics, Inc.
Change
17.43
▲
+0.87%
· post 17.43
Mkt cap
$3.8B
Revenue
$350,000
Q2 FY26
Revenue
—
AMGN
Amgen Inc
Change
460.67
▼
−1.03%
· post 456.16
Closed
Nov 3 '26
Mkt cap
$249.4B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 3 '26
RLAY
Relay Therapeutics, Inc.
vs
AMGN
Amgen Inc
17.43
▲
+0.87%
post 17.43
Price
460.67
▼
−1.03%
post 456.16
$3.8B
Mkt cap
$249.4B
Q2 FY26
$350,000
Revenue
$10.1B
Q2 FY26
—
Revenue
$36.8B
FY25
Change
Change
RLAY
17.43
▲
+0.87%
vs
AMGN
460.67
▼
−1.03%
Closed
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RLAY: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RLAY, solid
AMGN, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RLAY
3
—
D.E. Shaw Research
unlisted
supplier
—
Elevar Therapeutics
unlisted
customer
—
Genentech
unlisted
customer
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›